Belgium· BE-AMP-SAM110871-00
Estracyt 140 mg
A estramustine product containing estramustine sodium phosphate monohydrate, registered in Belgium by Pfizer. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Estramustine is registered in 3 of 19 countries.
Countries holding a registration under ATC L01XX11 (estramustine), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Estramustine · ATC L01XX11
3 / 19 countries
- Belgiumprice
- Finlandprice
- United Kingdom
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Estramustine Sodium Phosphate Monohydrate
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- L01XX11
- ATC class
- Estramustine
- Defined daily dose
- 0.56 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0040147
- be_apb0706580
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
126 interactions on record for estramustine.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Estramustine · interactions on record
126 records
- 2 severe
- 114 moderate
- 10 minor
Most severe, free to view
- Tranexamic acidB02AA02severe
- ThalidomideL04AX02severe
- Calcium carbonateA02AC01moderate
- Amphotericin BA07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Estramustine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ed4862f5-9c2f-40d7-abc3-e5845e2ba6ee GET /v1/drugs/ed4862f5-9c2f-40d7-abc3-e5845e2ba6ee?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Estracyt 140 mg",
"name_fr": "Estracyt 140 mg",
"name_nl": "Estracyt 140 mg",
"amp_code": "SAM110871-00",
"strengths": [
"156.7000",
"156.7000",
"140.0000",
"140.0000",
"2.0000"
],
"pack_count": 2,
"substances": [
"Estramustine Sodium Phosphate Monohydrate",
"Estramustine Phosphate",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Estramustine",
"authorisation_numbers": [
"BE110871"
]
}See everything about estramustine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.